Saint Luke’s

The Health Economics Technology Assessment Group (HETA), an independent functional unit within the Mid America Heart Institute (MAHI) will serve as the Health Economic Core Laboratory for the C-TRACT Trial. Its leaders have tremendous experience in performing health economic evaluations in randomized trials of cardiovascular interventions. HETA-MAHI serves as the Economics and Quality of Life Coordinating Center for 4 other NHLBI-funded randomized trials: the FREEDOM Trial (2400 patients, 5-years, coronary artery bypass graft surgery vs. percutaneous coronary intervention); the CORAL Trial (1080 patients, 5-years, renal artery stenting vs. medical therapy for renal artery stenosis); and the CREST Trial (2400 patients, 4-years, carotid artery stenting vs. carotid endarterectomy for symptomatic carotid artery stenosis), and the ATTRACT Trial (692 patients, 7 years, evaluated pharmacomechanical catheter-directed thrombolysis for acute proximal DVT).

In C-TRACT, MAHI will coordinate the collection of economic data on study participants to estimate the costs of the two treatment strategies.